$VITR #Vitrolife AB Vitrolife - Short-term pain: Lockdowns and precautionary recommendations hurt EBITDA down by 9-19% ‘20e-’21e Q1 report due 23 April https://t.co/qWF5QS54qt #equity #stocks https://t.co/5nM0YaMfRg